Is ARSSF or JNJ a better dividend investment in 2026?

ARSSF currently yields 7.37% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: ARSSF offers higher current income.

What is the dividend yield difference between ARSSF and JNJ?

ARSSF has a forward dividend yield of 7.37% ($0.05/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 4.01 percentage points.

Home › Compare › ARSSF vs JNJ

ARSSF vs JNJ: Dividend Comparison 2026

ARSSF yields 7.37% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ARSSF wins by $97.1K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ARSSF

● Live price

7.37%

Share price

$0.68

Annual div

$0.05

5Y div CAGR

25.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$117.1K

Annual income

$31,579.87

Full ARSSF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — ARSSF vs JNJ

📍 ARSSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ARSSF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ARSSF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ARSSF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARSSF

Annual income on $10K today (after 15% tax)

$626.84/yr

After 10yr DRIP, annual income (after tax)

$26,842.89/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, ARSSF beats the other by $26,139.28/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARSSF + JNJ for your $10,000?

ARSSF: 50%JNJ: 50%

100% JNJ50/50100% ARSSF

Portfolio after 10yr

$68.6K

Annual income

$16,203.83/yr

Blended yield

23.63%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ARSSF

Analyst Ratings

Hold

Consensus: Hold

Altman Z

0.9

Piotroski

5/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARSSF buys

JNJ buys

No recent congressional trades found for ARSSF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricARSSFJNJ

Forward yield	7.37% ✓	3.36%
Annual dividend / share	$0.05	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	25.7% ✓	5.8%
Portfolio after 10y	$117.1K ✓	$20.0K
Annual income after 10y	$31,579.87 ✓	$827.78
Total dividends collected	$85.6K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy

Year-by-year: ARSSF vs JNJ ($10,000, DRIP)

Year	ARSSF Portfolio	ARSSF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,627	$926.99	$10,676	$355.77	+$951.00 → ARSSF
2	$13,707	$1,266.18	$11,407	$389.39	+$2.3K → ARSSF
3	$16,420	$1,753.57	$12,198	$426.53	+$4.2K → ARSSF
4	$20,037	$2,467.78	$13,056	$467.62	+$7.0K → ARSSF
5	$24,978	$3,537.70	$13,987	$513.12	+$11.0K → ARSSF
6	$31,907	$5,180.65	$14,998	$563.56	+$16.9K → ARSSF
7	$41,915	$7,774.39	$16,098	$619.52	+$25.8K → ARSSF
8	$56,846	$11,997.78	$17,295	$681.69	+$39.6K → ARSSF
9	$79,941	$19,115.70	$18,599	$750.82	+$61.3K → ARSSF
10	$117,117	$31,579.87	$20,022	$827.78	+$97.1K → ARSSF

ARSSF vs JNJ: Complete Analysis 2026

ARSSF — Stock

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.

Full ARSSF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this ARSSF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARSSF vs SCHD ARSSF vs JEPI ARSSF vs O ARSSF vs KO ARSSF vs MAIN ARSSF vs ABBV ARSSF vs MRK ARSSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.